nodes	percent_of_prediction	percent_of_DWPC	metapath
Bedaquiline—CYP3A4—Everolimus—kidney cancer	0.199	0.293	CbGbCtD
Bedaquiline—CYP3A4—Temsirolimus—kidney cancer	0.134	0.198	CbGbCtD
Bedaquiline—CYP3A4—Pazopanib—kidney cancer	0.0706	0.104	CbGbCtD
Bedaquiline—CYP3A4—Erlotinib—kidney cancer	0.0504	0.0741	CbGbCtD
Bedaquiline—CYP3A4—Paclitaxel—kidney cancer	0.0461	0.0678	CbGbCtD
Bedaquiline—CYP3A4—Sorafenib—kidney cancer	0.041	0.0603	CbGbCtD
Bedaquiline—CYP3A4—Vinblastine—kidney cancer	0.0405	0.0595	CbGbCtD
Bedaquiline—CYP3A4—Vincristine—kidney cancer	0.0398	0.0585	CbGbCtD
Bedaquiline—CYP3A4—Sunitinib—kidney cancer	0.0332	0.0488	CbGbCtD
Bedaquiline—CYP3A4—Doxorubicin—kidney cancer	0.0249	0.0366	CbGbCtD
Bedaquiline—Hepatic enzyme increased—Gemcitabine—kidney cancer	0.00179	0.00563	CcSEcCtD
Bedaquiline—Hepatic function abnormal—Sunitinib—kidney cancer	0.00175	0.00551	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Pazopanib—kidney cancer	0.00169	0.00532	CcSEcCtD
Bedaquiline—Connective tissue disorder—Temsirolimus—kidney cancer	0.00167	0.00527	CcSEcCtD
Bedaquiline—Torsade de pointes—Capecitabine—kidney cancer	0.00166	0.00521	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Everolimus—kidney cancer	0.00165	0.00519	CcSEcCtD
Bedaquiline—Alanine aminotransferase increased—Everolimus—kidney cancer	0.00162	0.00508	CcSEcCtD
Bedaquiline—Cardiac disorder—Temsirolimus—kidney cancer	0.00158	0.00498	CcSEcCtD
Bedaquiline—Connective tissue disorder—Pazopanib—kidney cancer	0.00158	0.00496	CcSEcCtD
Bedaquiline—Haemoptysis—Capecitabine—kidney cancer	0.00157	0.00494	CcSEcCtD
Bedaquiline—Cerebrovascular accident—Sunitinib—kidney cancer	0.00156	0.00491	CcSEcCtD
Bedaquiline—Alanine aminotransferase increased—Erlotinib—kidney cancer	0.00156	0.00491	CcSEcCtD
Bedaquiline—Cardiac disorder—Pazopanib—kidney cancer	0.00149	0.00469	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Sorafenib—kidney cancer	0.00143	0.00451	CcSEcCtD
Bedaquiline—Hepatic function abnormal—Gemcitabine—kidney cancer	0.00141	0.00442	CcSEcCtD
Bedaquiline—Alanine aminotransferase increased—Sorafenib—kidney cancer	0.0014	0.00441	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Sunitinib—kidney cancer	0.00138	0.00434	CcSEcCtD
Bedaquiline—Alanine aminotransferase increased—Sunitinib—kidney cancer	0.00135	0.00425	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Everolimus—kidney cancer	0.00134	0.0042	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Dactinomycin—kidney cancer	0.0013	0.0041	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Erlotinib—kidney cancer	0.00129	0.00405	CcSEcCtD
Bedaquiline—Hepatitis—Everolimus—kidney cancer	0.00127	0.00399	CcSEcCtD
Bedaquiline—Arthralgia—Temsirolimus—kidney cancer	0.00126	0.00397	CcSEcCtD
Bedaquiline—Chest pain—Temsirolimus—kidney cancer	0.00126	0.00397	CcSEcCtD
Bedaquiline—Myalgia—Temsirolimus—kidney cancer	0.00126	0.00397	CcSEcCtD
Bedaquiline—Cerebrovascular accident—Gemcitabine—kidney cancer	0.00125	0.00394	CcSEcCtD
Bedaquiline—Connective tissue disorder—Everolimus—kidney cancer	0.00125	0.00392	CcSEcCtD
Bedaquiline—Transaminases increased—Doxorubicin—kidney cancer	0.00123	0.00387	CcSEcCtD
Bedaquiline—Hepatitis—Erlotinib—kidney cancer	0.00122	0.00385	CcSEcCtD
Bedaquiline—Connective tissue disorder—Erlotinib—kidney cancer	0.0012	0.00378	CcSEcCtD
Bedaquiline—Myalgia—Pazopanib—kidney cancer	0.00119	0.00374	CcSEcCtD
Bedaquiline—Chest pain—Pazopanib—kidney cancer	0.00119	0.00374	CcSEcCtD
Bedaquiline—Arthralgia—Pazopanib—kidney cancer	0.00119	0.00374	CcSEcCtD
Bedaquiline—Nervous system disorder—Temsirolimus—kidney cancer	0.00119	0.00374	CcSEcCtD
Bedaquiline—Cardiac disorder—Everolimus—kidney cancer	0.00118	0.0037	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Vincristine—kidney cancer	0.00117	0.00367	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Sorafenib—kidney cancer	0.00116	0.00365	CcSEcCtD
Bedaquiline—Anorexia—Temsirolimus—kidney cancer	0.00115	0.00363	CcSEcCtD
Bedaquiline—Nervous system disorder—Pazopanib—kidney cancer	0.00112	0.00352	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Sunitinib—kidney cancer	0.00112	0.00351	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Gemcitabine—kidney cancer	0.00111	0.00348	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Temsirolimus—kidney cancer	0.0011	0.00347	CcSEcCtD
Bedaquiline—Arrhythmia—Erlotinib—kidney cancer	0.00109	0.00344	CcSEcCtD
Bedaquiline—Anorexia—Pazopanib—kidney cancer	0.00109	0.00342	CcSEcCtD
Bedaquiline—Alanine aminotransferase increased—Gemcitabine—kidney cancer	0.00108	0.00341	CcSEcCtD
Bedaquiline—Connective tissue disorder—Sorafenib—kidney cancer	0.00108	0.0034	CcSEcCtD
Bedaquiline—Hepatitis—Sunitinib—kidney cancer	0.00106	0.00333	CcSEcCtD
Bedaquiline—Decreased appetite—Temsirolimus—kidney cancer	0.00105	0.00331	CcSEcCtD
Bedaquiline—Cerebrovascular accident—Paclitaxel—kidney cancer	0.00105	0.0033	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Temsirolimus—kidney cancer	0.00105	0.00329	CcSEcCtD
Bedaquiline—Connective tissue disorder—Sunitinib—kidney cancer	0.00104	0.00327	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Pazopanib—kidney cancer	0.00104	0.00327	CcSEcCtD
Bedaquiline—Cardiac disorder—Sorafenib—kidney cancer	0.00102	0.00321	CcSEcCtD
Bedaquiline—Haemoptysis—Doxorubicin—kidney cancer	0.00101	0.00318	CcSEcCtD
Bedaquiline—Hepatitis—Dactinomycin—kidney cancer	0.001	0.00315	CcSEcCtD
Bedaquiline—Decreased appetite—Pazopanib—kidney cancer	0.000991	0.00312	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Pazopanib—kidney cancer	0.000985	0.0031	CcSEcCtD
Bedaquiline—Arrhythmia—Sorafenib—kidney cancer	0.000983	0.00309	CcSEcCtD
Bedaquiline—Cardiac disorder—Sunitinib—kidney cancer	0.000983	0.00309	CcSEcCtD
Bedaquiline—Hepatic function abnormal—Capecitabine—kidney cancer	0.000965	0.00304	CcSEcCtD
Bedaquiline—Arrhythmia—Sunitinib—kidney cancer	0.000946	0.00298	CcSEcCtD
Bedaquiline—Arthralgia—Everolimus—kidney cancer	0.000939	0.00296	CcSEcCtD
Bedaquiline—Chest pain—Everolimus—kidney cancer	0.000939	0.00296	CcSEcCtD
Bedaquiline—Myalgia—Everolimus—kidney cancer	0.000939	0.00296	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Paclitaxel—kidney cancer	0.000926	0.00291	CcSEcCtD
Bedaquiline—Alanine aminotransferase increased—Paclitaxel—kidney cancer	0.000907	0.00285	CcSEcCtD
Bedaquiline—Myalgia—Erlotinib—kidney cancer	0.000906	0.00285	CcSEcCtD
Bedaquiline—Chest pain—Erlotinib—kidney cancer	0.000906	0.00285	CcSEcCtD
Bedaquiline—Arthralgia—Erlotinib—kidney cancer	0.000906	0.00285	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Gemcitabine—kidney cancer	0.000895	0.00282	CcSEcCtD
Bedaquiline—Nervous system disorder—Everolimus—kidney cancer	0.000883	0.00278	CcSEcCtD
Bedaquiline—Connective tissue disorder—Vincristine—kidney cancer	0.00088	0.00277	CcSEcCtD
Bedaquiline—Toremifene—CYP1A1—kidney cancer	0.000862	0.386	CrCbGaD
Bedaquiline—Anorexia—Vinblastine—kidney cancer	0.000862	0.00271	CcSEcCtD
Bedaquiline—Cerebrovascular accident—Capecitabine—kidney cancer	0.000861	0.00271	CcSEcCtD
Bedaquiline—Anorexia—Everolimus—kidney cancer	0.000858	0.0027	CcSEcCtD
Bedaquiline—Nervous system disorder—Erlotinib—kidney cancer	0.000852	0.00268	CcSEcCtD
Bedaquiline—Connective tissue disorder—Gemcitabine—kidney cancer	0.000835	0.00263	CcSEcCtD
Bedaquiline—Cardiac disorder—Vincristine—kidney cancer	0.000831	0.00261	CcSEcCtD
Bedaquiline—Diarrhoea—Temsirolimus—kidney cancer	0.000828	0.00261	CcSEcCtD
Bedaquiline—Anorexia—Erlotinib—kidney cancer	0.000828	0.00261	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Everolimus—kidney cancer	0.00082	0.00258	CcSEcCtD
Bedaquiline—Myalgia—Sorafenib—kidney cancer	0.000815	0.00257	CcSEcCtD
Bedaquiline—Arthralgia—Sorafenib—kidney cancer	0.000815	0.00257	CcSEcCtD
Bedaquiline—Dizziness—Temsirolimus—kidney cancer	0.000801	0.00252	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.000792	0.00249	CcSEcCtD
Bedaquiline—Cardiac disorder—Gemcitabine—kidney cancer	0.000788	0.00248	CcSEcCtD
Bedaquiline—Decreased appetite—Vinblastine—kidney cancer	0.000786	0.00247	CcSEcCtD
Bedaquiline—Myalgia—Sunitinib—kidney cancer	0.000785	0.00247	CcSEcCtD
Bedaquiline—Arthralgia—Sunitinib—kidney cancer	0.000785	0.00247	CcSEcCtD
Bedaquiline—Chest pain—Sunitinib—kidney cancer	0.000785	0.00247	CcSEcCtD
Bedaquiline—Decreased appetite—Everolimus—kidney cancer	0.000783	0.00246	CcSEcCtD
Bedaquiline—Diarrhoea—Pazopanib—kidney cancer	0.00078	0.00246	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Everolimus—kidney cancer	0.000777	0.00245	CcSEcCtD
Bedaquiline—Vomiting—Temsirolimus—kidney cancer	0.00077	0.00242	CcSEcCtD
Bedaquiline—Nervous system disorder—Sorafenib—kidney cancer	0.000767	0.00241	CcSEcCtD
Bedaquiline—Rash—Temsirolimus—kidney cancer	0.000763	0.0024	CcSEcCtD
Bedaquiline—Dermatitis—Temsirolimus—kidney cancer	0.000763	0.0024	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Capecitabine—kidney cancer	0.00076	0.00239	CcSEcCtD
Bedaquiline—Arrhythmia—Gemcitabine—kidney cancer	0.000759	0.00239	CcSEcCtD
Bedaquiline—Headache—Temsirolimus—kidney cancer	0.000758	0.00239	CcSEcCtD
Bedaquiline—Decreased appetite—Erlotinib—kidney cancer	0.000755	0.00238	CcSEcCtD
Bedaquiline—Dizziness—Pazopanib—kidney cancer	0.000754	0.00237	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Erlotinib—kidney cancer	0.00075	0.00236	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Paclitaxel—kidney cancer	0.000749	0.00236	CcSEcCtD
Bedaquiline—Anorexia—Sorafenib—kidney cancer	0.000745	0.00234	CcSEcCtD
Bedaquiline—Alanine aminotransferase increased—Capecitabine—kidney cancer	0.000744	0.00234	CcSEcCtD
Bedaquiline—Myalgia—Dactinomycin—kidney cancer	0.000743	0.00234	CcSEcCtD
Bedaquiline—Nervous system disorder—Sunitinib—kidney cancer	0.000738	0.00232	CcSEcCtD
Bedaquiline—Vomiting—Pazopanib—kidney cancer	0.000725	0.00228	CcSEcCtD
Bedaquiline—Rash—Pazopanib—kidney cancer	0.000719	0.00226	CcSEcCtD
Bedaquiline—Nausea—Temsirolimus—kidney cancer	0.000719	0.00226	CcSEcCtD
Bedaquiline—Dermatitis—Pazopanib—kidney cancer	0.000718	0.00226	CcSEcCtD
Bedaquiline—Anorexia—Sunitinib—kidney cancer	0.000717	0.00226	CcSEcCtD
Bedaquiline—Headache—Pazopanib—kidney cancer	0.000714	0.00225	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000712	0.00224	CcSEcCtD
Bedaquiline—Connective tissue disorder—Paclitaxel—kidney cancer	0.000699	0.0022	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000685	0.00216	CcSEcCtD
Bedaquiline—Decreased appetite—Sorafenib—kidney cancer	0.000679	0.00214	CcSEcCtD
Bedaquiline—Anorexia—Dactinomycin—kidney cancer	0.000679	0.00214	CcSEcCtD
Bedaquiline—Nausea—Pazopanib—kidney cancer	0.000677	0.00213	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000675	0.00212	CcSEcCtD
Bedaquiline—Myalgia—Vincristine—kidney cancer	0.000664	0.00209	CcSEcCtD
Bedaquiline—Cardiac disorder—Paclitaxel—kidney cancer	0.00066	0.00208	CcSEcCtD
Bedaquiline—Decreased appetite—Sunitinib—kidney cancer	0.000654	0.00206	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000649	0.00204	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000649	0.00204	CcSEcCtD
Bedaquiline—Arrhythmia—Paclitaxel—kidney cancer	0.000635	0.002	CcSEcCtD
Bedaquiline—Chest pain—Gemcitabine—kidney cancer	0.00063	0.00198	CcSEcCtD
Bedaquiline—Myalgia—Gemcitabine—kidney cancer	0.00063	0.00198	CcSEcCtD
Bedaquiline—Arthralgia—Gemcitabine—kidney cancer	0.00063	0.00198	CcSEcCtD
Bedaquiline—Nervous system disorder—Vincristine—kidney cancer	0.000624	0.00196	CcSEcCtD
Bedaquiline—Hepatic function abnormal—Doxorubicin—kidney cancer	0.000622	0.00196	CcSEcCtD
Bedaquiline—Decreased appetite—Dactinomycin—kidney cancer	0.000619	0.00195	CcSEcCtD
Bedaquiline—Diarrhoea—Vinblastine—kidney cancer	0.000618	0.00195	CcSEcCtD
Bedaquiline—Diarrhoea—Everolimus—kidney cancer	0.000616	0.00194	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Capecitabine—kidney cancer	0.000615	0.00193	CcSEcCtD
Bedaquiline—Anorexia—Vincristine—kidney cancer	0.000606	0.00191	CcSEcCtD
Bedaquiline—Dizziness—Vinblastine—kidney cancer	0.000598	0.00188	CcSEcCtD
Bedaquiline—Dizziness—Everolimus—kidney cancer	0.000595	0.00187	CcSEcCtD
Bedaquiline—Diarrhoea—Erlotinib—kidney cancer	0.000594	0.00187	CcSEcCtD
Bedaquiline—Nervous system disorder—Gemcitabine—kidney cancer	0.000592	0.00186	CcSEcCtD
Bedaquiline—Hepatitis—Capecitabine—kidney cancer	0.000584	0.00184	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Vincristine—kidney cancer	0.00058	0.00182	CcSEcCtD
Bedaquiline—Anorexia—Gemcitabine—kidney cancer	0.000575	0.00181	CcSEcCtD
Bedaquiline—Vomiting—Vinblastine—kidney cancer	0.000575	0.00181	CcSEcCtD
Bedaquiline—Dizziness—Erlotinib—kidney cancer	0.000575	0.00181	CcSEcCtD
Bedaquiline—Connective tissue disorder—Capecitabine—kidney cancer	0.000574	0.0018	CcSEcCtD
Bedaquiline—Vomiting—Everolimus—kidney cancer	0.000573	0.0018	CcSEcCtD
Bedaquiline—Rash—Everolimus—kidney cancer	0.000568	0.00179	CcSEcCtD
Bedaquiline—Dermatitis—Everolimus—kidney cancer	0.000567	0.00178	CcSEcCtD
Bedaquiline—Headache—Vinblastine—kidney cancer	0.000566	0.00178	CcSEcCtD
Bedaquiline—Headache—Everolimus—kidney cancer	0.000564	0.00177	CcSEcCtD
Bedaquiline—Cerebrovascular accident—Doxorubicin—kidney cancer	0.000555	0.00175	CcSEcCtD
Bedaquiline—Decreased appetite—Vincristine—kidney cancer	0.000553	0.00174	CcSEcCtD
Bedaquiline—Vomiting—Erlotinib—kidney cancer	0.000552	0.00174	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.00055	0.00173	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Vincristine—kidney cancer	0.000549	0.00173	CcSEcCtD
Bedaquiline—Rash—Erlotinib—kidney cancer	0.000548	0.00172	CcSEcCtD
Bedaquiline—Dermatitis—Erlotinib—kidney cancer	0.000547	0.00172	CcSEcCtD
Bedaquiline—Headache—Erlotinib—kidney cancer	0.000544	0.00171	CcSEcCtD
Bedaquiline—Cardiac disorder—Capecitabine—kidney cancer	0.000542	0.0017	CcSEcCtD
Bedaquiline—Nausea—Vinblastine—kidney cancer	0.000537	0.00169	CcSEcCtD
Bedaquiline—Nausea—Everolimus—kidney cancer	0.000535	0.00168	CcSEcCtD
Bedaquiline—Diarrhoea—Sorafenib—kidney cancer	0.000535	0.00168	CcSEcCtD
Bedaquiline—Arthralgia—Paclitaxel—kidney cancer	0.000527	0.00166	CcSEcCtD
Bedaquiline—Chest pain—Paclitaxel—kidney cancer	0.000527	0.00166	CcSEcCtD
Bedaquiline—Myalgia—Paclitaxel—kidney cancer	0.000527	0.00166	CcSEcCtD
Bedaquiline—Decreased appetite—Gemcitabine—kidney cancer	0.000525	0.00165	CcSEcCtD
Bedaquiline—Arrhythmia—Capecitabine—kidney cancer	0.000521	0.00164	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000521	0.00164	CcSEcCtD
Bedaquiline—Dizziness—Sorafenib—kidney cancer	0.000517	0.00163	CcSEcCtD
Bedaquiline—Nausea—Erlotinib—kidney cancer	0.000516	0.00162	CcSEcCtD
Bedaquiline—Diarrhoea—Sunitinib—kidney cancer	0.000515	0.00162	CcSEcCtD
Bedaquiline—Dizziness—Sunitinib—kidney cancer	0.000497	0.00156	CcSEcCtD
Bedaquiline—Vomiting—Sorafenib—kidney cancer	0.000497	0.00156	CcSEcCtD
Bedaquiline—Nervous system disorder—Paclitaxel—kidney cancer	0.000496	0.00156	CcSEcCtD
Bedaquiline—Rash—Sorafenib—kidney cancer	0.000493	0.00155	CcSEcCtD
Bedaquiline—Dermatitis—Sorafenib—kidney cancer	0.000492	0.00155	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.00049	0.00154	CcSEcCtD
Bedaquiline—Headache—Sorafenib—kidney cancer	0.00049	0.00154	CcSEcCtD
Bedaquiline—Diarrhoea—Dactinomycin—kidney cancer	0.000487	0.00153	CcSEcCtD
Bedaquiline—Anorexia—Paclitaxel—kidney cancer	0.000482	0.00152	CcSEcCtD
Bedaquiline—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.00048	0.00151	CcSEcCtD
Bedaquiline—Vomiting—Sunitinib—kidney cancer	0.000478	0.0015	CcSEcCtD
Bedaquiline—Rash—Sunitinib—kidney cancer	0.000474	0.00149	CcSEcCtD
Bedaquiline—Dermatitis—Sunitinib—kidney cancer	0.000474	0.00149	CcSEcCtD
Bedaquiline—Headache—Sunitinib—kidney cancer	0.000471	0.00148	CcSEcCtD
Bedaquiline—Nausea—Sorafenib—kidney cancer	0.000464	0.00146	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.00046	0.00145	CcSEcCtD
Bedaquiline—Toremifene—ABCB1—kidney cancer	0.000458	0.205	CrCbGaD
Bedaquiline—Vomiting—Dactinomycin—kidney cancer	0.000453	0.00142	CcSEcCtD
Bedaquiline—Rash—Dactinomycin—kidney cancer	0.000449	0.00141	CcSEcCtD
Bedaquiline—Nausea—Sunitinib—kidney cancer	0.000447	0.00141	CcSEcCtD
Bedaquiline—Decreased appetite—Paclitaxel—kidney cancer	0.000439	0.00138	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000436	0.00137	CcSEcCtD
Bedaquiline—Diarrhoea—Vincristine—kidney cancer	0.000435	0.00137	CcSEcCtD
Bedaquiline—Arthralgia—Capecitabine—kidney cancer	0.000433	0.00136	CcSEcCtD
Bedaquiline—Chest pain—Capecitabine—kidney cancer	0.000433	0.00136	CcSEcCtD
Bedaquiline—Myalgia—Capecitabine—kidney cancer	0.000433	0.00136	CcSEcCtD
Bedaquiline—Nausea—Dactinomycin—kidney cancer	0.000423	0.00133	CcSEcCtD
Bedaquiline—Dizziness—Vincristine—kidney cancer	0.000421	0.00132	CcSEcCtD
Bedaquiline—Diarrhoea—Gemcitabine—kidney cancer	0.000413	0.0013	CcSEcCtD
Bedaquiline—Nervous system disorder—Capecitabine—kidney cancer	0.000407	0.00128	CcSEcCtD
Bedaquiline—Vomiting—Vincristine—kidney cancer	0.000404	0.00127	CcSEcCtD
Bedaquiline—Rash—Vincristine—kidney cancer	0.000401	0.00126	CcSEcCtD
Bedaquiline—Dermatitis—Vincristine—kidney cancer	0.000401	0.00126	CcSEcCtD
Bedaquiline—Headache—Vincristine—kidney cancer	0.000399	0.00125	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000396	0.00125	CcSEcCtD
Bedaquiline—Anorexia—Capecitabine—kidney cancer	0.000395	0.00124	CcSEcCtD
Bedaquiline—Diphenhydramine—PTGS1—kidney cancer	0.000387	0.173	CrCbGaD
Bedaquiline—Vomiting—Gemcitabine—kidney cancer	0.000384	0.00121	CcSEcCtD
Bedaquiline—Rash—Gemcitabine—kidney cancer	0.000381	0.0012	CcSEcCtD
Bedaquiline—Dermatitis—Gemcitabine—kidney cancer	0.00038	0.0012	CcSEcCtD
Bedaquiline—Headache—Gemcitabine—kidney cancer	0.000378	0.00119	CcSEcCtD
Bedaquiline—Nausea—Vincristine—kidney cancer	0.000378	0.00119	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000378	0.00119	CcSEcCtD
Bedaquiline—Hepatitis—Doxorubicin—kidney cancer	0.000376	0.00118	CcSEcCtD
Bedaquiline—Connective tissue disorder—Doxorubicin—kidney cancer	0.00037	0.00116	CcSEcCtD
Bedaquiline—Decreased appetite—Capecitabine—kidney cancer	0.00036	0.00113	CcSEcCtD
Bedaquiline—Nausea—Gemcitabine—kidney cancer	0.000358	0.00113	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000358	0.00113	CcSEcCtD
Bedaquiline—Cardiac disorder—Doxorubicin—kidney cancer	0.000349	0.0011	CcSEcCtD
Bedaquiline—Diarrhoea—Paclitaxel—kidney cancer	0.000346	0.00109	CcSEcCtD
Bedaquiline—Tamoxifen—CYP1A1—kidney cancer	0.000344	0.154	CrCbGaD
Bedaquiline—Arrhythmia—Doxorubicin—kidney cancer	0.000336	0.00106	CcSEcCtD
Bedaquiline—Dizziness—Paclitaxel—kidney cancer	0.000334	0.00105	CcSEcCtD
Bedaquiline—Vomiting—Paclitaxel—kidney cancer	0.000321	0.00101	CcSEcCtD
Bedaquiline—Rash—Paclitaxel—kidney cancer	0.000319	0.001	CcSEcCtD
Bedaquiline—Dermatitis—Paclitaxel—kidney cancer	0.000318	0.001	CcSEcCtD
Bedaquiline—Headache—Paclitaxel—kidney cancer	0.000317	0.000996	CcSEcCtD
Bedaquiline—Nausea—Paclitaxel—kidney cancer	0.0003	0.000944	CcSEcCtD
Bedaquiline—Diarrhoea—Capecitabine—kidney cancer	0.000284	0.000893	CcSEcCtD
Bedaquiline—Arthralgia—Doxorubicin—kidney cancer	0.000279	0.000877	CcSEcCtD
Bedaquiline—Chest pain—Doxorubicin—kidney cancer	0.000279	0.000877	CcSEcCtD
Bedaquiline—Myalgia—Doxorubicin—kidney cancer	0.000279	0.000877	CcSEcCtD
Bedaquiline—Dizziness—Capecitabine—kidney cancer	0.000274	0.000863	CcSEcCtD
Bedaquiline—Vomiting—Capecitabine—kidney cancer	0.000264	0.00083	CcSEcCtD
Bedaquiline—Nervous system disorder—Doxorubicin—kidney cancer	0.000262	0.000825	CcSEcCtD
Bedaquiline—Rash—Capecitabine—kidney cancer	0.000261	0.000823	CcSEcCtD
Bedaquiline—Dermatitis—Capecitabine—kidney cancer	0.000261	0.000822	CcSEcCtD
Bedaquiline—Headache—Capecitabine—kidney cancer	0.00026	0.000817	CcSEcCtD
Bedaquiline—Anorexia—Doxorubicin—kidney cancer	0.000255	0.000802	CcSEcCtD
Bedaquiline—Nausea—Capecitabine—kidney cancer	0.000246	0.000775	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000244	0.000766	CcSEcCtD
Bedaquiline—Decreased appetite—Doxorubicin—kidney cancer	0.000232	0.000731	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000231	0.000726	CcSEcCtD
Bedaquiline—Tamoxifen—ABCB1—kidney cancer	0.000183	0.0819	CrCbGaD
Bedaquiline—Diarrhoea—Doxorubicin—kidney cancer	0.000183	0.000575	CcSEcCtD
Bedaquiline—Dizziness—Doxorubicin—kidney cancer	0.000177	0.000556	CcSEcCtD
Bedaquiline—Vomiting—Doxorubicin—kidney cancer	0.00017	0.000535	CcSEcCtD
Bedaquiline—Rash—Doxorubicin—kidney cancer	0.000169	0.00053	CcSEcCtD
Bedaquiline—Dermatitis—Doxorubicin—kidney cancer	0.000168	0.00053	CcSEcCtD
Bedaquiline—Headache—Doxorubicin—kidney cancer	0.000167	0.000527	CcSEcCtD
Bedaquiline—Nausea—Doxorubicin—kidney cancer	0.000159	0.0005	CcSEcCtD
